Learning Objectives:

1: Appreciate the value of immunotherpay in treatmett nof stage IV NSCLC

2: Understand the expanding role of immunotherpay in resectable NSCLC

3: Recognize contrindications to use of immunotherapy in resectable NSCLC

Session date: 
Wednesday, December 9, 2020 - 7:15am to 8:15am
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jessica S Donington, MD